APA aipamena

Arif, S., Gomez-Tourino, I., Kamra, Y., Pujol-Autonell, I., Hanton, E., Tree, T., . . . Peakman, M. (2020). GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. Diabetologia.

Chicago Style aipamena

Arif, Sefina, et al. "GAD-alum Immunotherapy in Type 1 Diabetes Expands Bifunctional Th1/Th2 Autoreactive CD4 T Cells." Diabetologia 2020.

MLA aipamena

Arif, Sefina, et al. "GAD-alum Immunotherapy in Type 1 Diabetes Expands Bifunctional Th1/Th2 Autoreactive CD4 T Cells." Diabetologia 2020.